Sat.Dec 18, 2021 - Fri.Dec 24, 2021

article thumbnail

Oxford and AstraZeneca aim to produce Omicron-targeted version of vaccine

Pharma Times

Calls for booster vaccinations in order to combat the rising cases brought about by winter and the recent Omicron variant have intensified, in the midst of record case rates.

Vaccines 121
article thumbnail

Sanofi buys US immuno-oncology biotech Amunix for $1 billion

pharmaphorum

Sanofi has bolstered its immuno-oncology pipeline with a $1 billion agreement to acquire Amunix Pharma of the US – its fourth bolt-on deal of 2021. South San Francisco-based Amunix specialises in T-cell engager and cytokine-based treatments for solid tumours, and is planning to advance its lead programme AMX-818 – a cell-based therapy which targets HER2-expressing cancers – into the clinic next year.

123
123
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bias in artificial intelligence impacts drug development: AiCure

Outsourcing Pharma

According to an expert from the clinical insights company, prejudice in AI can impact patient outcomes as well as the ability to develop effective treatments.

article thumbnail

Watch: DHC Roundtable Discussion

Pharma Marketing Network

R.J. Lewis, Founder and CEO of eHealthcare Solutions and Tap Native and the Chief Collaborator at Pharma Marketing Network, moderated a deep dive discussion on the topic of physician-level data (PLD) with a focus around drivers for the tool, its usage, and successes learnings about its function in pharma, and the where it’s heading. Guests of the panel included experts from GSK, Ispen, BioPharm Communications, and CMI, who all spoke to the importance of incorporating and leveraging PLD ins

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Cancer researchers across the UK partner in new trial to find drugs for rare cancers

Pharma Times

The DETERMINE trial aims to discover whether existing ‘licensed’ drugs could also benefit patients with rare cancer types that the drug is not currently licensed for.

118
118
article thumbnail

US health department backs 15 COVID-focused digital health startups

pharmaphorum

A group of 15 digital health startups have joined a programme set up by the US federal government to address health inequality and mitigate the effects if the COVID-19 pandemic. The PandemicX accelerator, launched by the Department of Health and Human Services, is focused on “using digital tools and publicly accessible data to eliminate disparities and tackle drivers of inequity exacerbated by COVID-19.” Companies that have been invited to take part will get “curriculum, mentor

Vaccines 119

More Trending

article thumbnail

Which pharmaceutical companies have the most drug patents in Czech Republic?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Czech Republic. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…. The post Which pharmaceutical companies have the most drug patents in Czech Republic? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Pfizer to provide UK with additional 2.5 treatment courses of Paxlovid

Pharma Times

With authorisation, Pfizer’s oral antiviral candidate Paxlovid is an investigational SARS-CoV-2 protease inhibitor could be prescribed at the first sign of COVID-19 infection.

101
101
article thumbnail

Biogen, Eisai Alzheimer’s drug lecanemab fast tracked by FDA

pharmaphorum

Biogen and Eisai head towards the end of the year with some much-needed good news in their Alzheimer’s programmes, as the FDA awards a fast-track designation to lecanemab, their follow-up to recently approved Aduhelm. The anti-amyloid drug, which also claimed a breakthrough tag from the FDA in July, is being developed for the treatment of early-stage Alzheimer’s disease.

111
111
article thumbnail

Dogs, VR, and rock stars: OSP’s favorite items of 2021

Outsourcing Pharma

It has been a pleasure for the OSP team to connect with a long list of fascinating industry minds and share the stories; here are a few of our favorites.

119
119
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

New patent for Amgen Inc drug CORLANOR

Drug Patent Watch

Annual Drug Patent Expirations for CORLANOR Corlanor is a drug marketed by Amgen Inc and is included in two NDAs. It is available from one supplier. There are eight patents…. The post New patent for Amgen Inc drug CORLANOR appeared first on DrugPatentWatch - Make Better Decisions.

89
article thumbnail

Positive CHMP opinion for finerenone as new treatment for chronic kidney disease and type 2 diabetes

Pharma Times

It is estimated that chronic kidney disease affects more than 160 million people with type 2 diabetes worldwide.

Diabetes 112
article thumbnail

NICE backs Aimmune’s peanut allergy drug Palforzia for children

pharmaphorum

Children in England with peanut allergies could be among the first in Europe to get access to Aimmune’s oral immunotherapy Palforzia, after the drugmaker agreed a supply deal with NHS England. The deal comes as cost-effectiveness watchdog NICE recommended Palforzia for NHS use in draft guidance published today which says the drug can be effective in inducing tolerance to peanuts and reducing the severity of allergic reactions, including potentially life-threatening anaphylaxis.

119
119
article thumbnail

Purchases, pandemic, and potential treatments: 2021’s greatest hits

Outsourcing Pharma

OSPâs list of the yearâs most-read stories shows readers are interested in M&A activities, new drug candidates, COVID-19 developments, and other hot news.

98
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Merck’s Covid Pill Is Authorized by F.D.A. for High-Risk Adults

NY Times

The F.D.A. said the drug should be prescribed mainly when other treatments were “not accessible or clinically appropriate.”.

104
104
article thumbnail

CHMP recommend Saphnelo for systematic lupus erythematosus

Pharma Times

With approval, Saphnelo would be the first available treatment for systematic lupus erythematosus in Europe in over ten years.

105
105
article thumbnail

Leveraging augmented analytics to drive better business decisions

pharmaphorum

In early 2020, health officials were cautious about forecasting a COVID-19 vaccine timeline to the public, as vaccine discovery was a historically laborious process that took years (if not decades). Yet a successful COVID-19 vaccine gained emergency approval in just 11 months, a blistering pace that likely saved millions of lives. Such a fast turnaround would not have been possible without advanced analytics and the troves of intelligence that scientists had at their disposal.

article thumbnail

New patent for Allergan Holdings drug VIBERZI

Drug Patent Watch

Annual Drug Patent Expirations for VIBERZI Viberzi is a drug marketed by Allergan Holdings and is included in one NDA. It is available from one supplier. There are sixteen patents…. The post New patent for Allergan Holdings drug VIBERZI appeared first on DrugPatentWatch - Make Better Decisions.

87
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Drug Channels News Roundup, December 2021: CAR-T Profits, UM Boom, Health Plans vs. Experts, Confused Physicians, and Health Insurance Explained

Drug Channels

Happy New Year, everyone! We made it through a challenging 2021. Ring in 2022 with these noisemakers from the Drug Channels party bag: Hospitals earn incredible markups on CAR-T therapies Utilization management booms Health plans often ignore clinical guidelines Benefit designs flummox physicians Plus: an awesomely concise summary of U.S. health insurance.

article thumbnail

COVID-19 vaccine should be offered to vulnerable children aged five to 11-years-old

Pharma Times

Government vaccine advisers have said vulnerable primary school children should be offered a low-dose of a COVID-19 vaccine.

Vaccines 103
article thumbnail

Mydecine, Maya team up on digital tools for psychedelic drugs

pharmaphorum

Psychedelic medicines developer Mydecine has joined forces with digital health company Maya to make digital tools that will be used alongside its drug candidates for mental health and addiction disorders. The aim is to develop the digital therapeutics (DTx) and new drug therapies in tandem, so that they can be co-prescribed by physicians and – at least in theory – improve the effectiveness of treatment.

article thumbnail

F.D.A. Clears Pfizer’s Covid Pill for High-Risk Patients 12 and Older

NY Times

The first-of-its-kind treatment, Paxlovid, has been found to be highly protective against severe illness. It could be available within a few days.

85
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

What Changes To Your Lifestyle Need To Be Done After Bariatric Surgery

Pharma Mirror

Getting bariatric surgery is a lifesaver for many people. It can dramatically improve the quality of life of those that are having problems because of their obesity. It reduces and even eliminates diabetes in many people and seriously reduces the risk of heart disease. The weight loss can be dramatic as well. Starting almost immediately after the surgery, the pounds fall away with ease.

article thumbnail

Xeris Biopharma’s glucagon injection becomes available in UK

Pharma Times

Tetris Pharma’s Ogluo is the first ready-to-use, pre-mixed and pre-measured glucagon injection.

109
109
article thumbnail

FDA sets out its stall on digital tools for remote clinical trials

pharmaphorum

The FDA has published draft guidance on how digital health technologies (DHTs) like smart and wearable devices can be used to capture data remotely from patients in clinical trials – an approach that has come to the fore since the start of the pandemic. The new guidance sets out the regulator’s current thinking on how trial sponsors to incorporate DHTs in the design of studies of drugs or medical devices.

article thumbnail

Walgreens and CVS Limit Purchases of At-Home Coronavirus Tests

NY Times

The caps come as the rapid spread of the Omicron variant has customers flocking to testing sites and pharmacies, which are struggling to keep up.

80
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Which pharmaceutical companies have the most lotion dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most lotion dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most lotion dosed drugs…. The post Which pharmaceutical companies have the most lotion dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

AstraZeneca and Novavax say their vaccines are effective against Omicron

Pharma Times

WHO officials remain cautious about claiming Omicron as a milder variant of the COVID-19 virus.

Vaccines 109
article thumbnail

2021 in review: Building the framework of a patient-centric industry

pharmaphorum

Patient centricity and patient engagement have been hot topics in pharma for some time – but buzz words do not always translate into concrete action. However, we have seen a framework of guidelines and recommendations during the last year on everything from increasing diversity to producing lay summaries, start to take shape. As part of our 2021 in Review series, we look back over some of these developments.

article thumbnail

Family in Nigeria Lost 3 Daughters to Sickle Cell. Can They Save a Fourth?

NY Times

About 150,000 babies are born each year in Nigeria with sickle cell, a deadly disease. Tens of thousands of them die annually before their fifth birthdays.

76
article thumbnail

December 24: The Weary World Rejoices

Pharma Packaging Solutions

So he came and proclaimed peace to you who were far off and peace to those who were near, for through him both of us have access in one Spirit to the Father. So then you are no longer strangers and aliens, but you are citizens with the saints and also members of the household of God. Ephesians 2:17-19 NRSV God’s purpose and longing for his creation has always been that we might not only be recipients of his great love and peace, but that we might be his partners in bringing that love and peace t

52